International Journal of Cancer · 2004 · 68 citations · 5 references
Life SciencesImmunologyOncologyMolecular OncologyMolecular VirologyVirologyAntibody CharacterizationGerm Cell TumorsMalignant NeoplasmsOncogenic VirusesSerological DiagnosticsTumor AntigensAntibodiesGerm Cell Tumor BiologyGerm Cell Tumor BiomarkersGerm Cell Tumor ChemotherapyGerm Cell Tumor PathologySerological DetectionTumor Antibody ResponsesViral Tumor Antigens
Germ cell tumors (GCT) are strictly associated with the expression of HERV-K(HML-2) proviruses, and the majority of GCT patients produce antibodies to structural proteins of these proviruses. The objective of our study was to determine the significance of the serological response to HERV-K(HML-2) Gag and Env proteins for diagnosis, management of GCT patients and estimation of the therapy success. The data document a strong association of HERV-K(HML-2) antibodies and the clinical manifestation of the disease and therapy success. HERV-K(HML-2) antibodies seem to have an important diagnostic value as well as indicator of chemotherapy success.
5
Practical Statistics for Medical Research.
Sophie Walter, Daniel Altman · Biometrics · 1992 · 11.7K citations
CONSORT statement: extension to cluster randomised trials
Marion Campbell, Diana R Elbourne, Douglas G. Altman · BMJ · 2004 · 2.6K citations · Full text